Reported Earnings • May 17
First quarter 2026 earnings released: US$1.00 loss per share (vs US$0.34 loss in 1Q 2025) First quarter 2026 results: US$1.00 loss per share (further deteriorated from US$0.34 loss in 1Q 2025). Net loss: US$33.3m (loss widened 349% from 1Q 2025). Revenue is expected to fall by 1.9% p.a. on average during the next 2 years compared to a 42% decline forecast for the Capital Markets industry in Canada. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 29
Full year 2025 earnings released: US$1.25 loss per share (vs US$0.75 loss in FY 2024) Full year 2025 results: US$1.25 loss per share (further deteriorated from US$0.75 loss in FY 2024). Revenue: US$67.6m (up 75% from FY 2024). Net loss: US$38.0m (loss widened 135% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 92 percentage points per year, which is a significant difference in performance. Announcement • Mar 17
The Westaim Corporation, Annual General Meeting, May 19, 2026 The Westaim Corporation, Annual General Meeting, May 19, 2026. Location: new york, new york United States Reported Earnings • Nov 16
Third quarter 2025 earnings released: US$0.35 loss per share (vs US$0.055 loss in 3Q 2024) Third quarter 2025 results: US$0.35 loss per share (further deteriorated from US$0.055 loss in 3Q 2024). Revenue: US$18.4m (up 62% from 3Q 2024). Net loss: US$11.6m (loss widened US$10.5m from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Sep 17
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.0% to CA$29.07. The fair value is estimated to be CA$36.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Aug 25
Second quarter 2025 earnings released: EPS: US$0.014 (vs US$0.80 loss in 2Q 2024) Second quarter 2025 results: EPS: US$0.014 (up from US$0.80 loss in 2Q 2024). Net income: US$455.0k (up US$17.5m from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Jul 31
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.1% to CA$29.90. The fair value is estimated to be CA$37.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jul 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.4% to CA$30.00. The fair value is estimated to be CA$37.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company became loss making. New Risk • May 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 57% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. Reported Earnings • May 16
First quarter 2025 earnings released: US$0.34 loss per share (vs US$1.07 profit in 1Q 2024) First quarter 2025 results: US$0.34 loss per share (down from US$1.07 profit in 1Q 2024). Net loss: US$7.43m (down 132% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • May 16
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.4% to CA$32.16. The fair value is estimated to be CA$41.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company became loss making. Announcement • Apr 07
The Westaim Corporation, Annual General Meeting, Jun 12, 2025 The Westaim Corporation, Annual General Meeting, Jun 12, 2025. Location: ontario, toronto Canada Board Change • Apr 04
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Menes Chee was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Announcement • Apr 04
The Westaim Corporation announced that it has received CAD 341.525 million in funding On April 3, 2025, The Westaim Corporation closed the transaction. The company issued securities for aggregate gross proceeds to the company of CAD 250 million pursuant to an investment agreement the Investor, Westaim, and, solely for purposes of specific sections of the investment agreement, AIGH, Mr. Zwirn and Mr. Cutler, as amended on November 15, 2024: (a) 11,979,825 common shares of Westaim at an implied purchase price of CAD 28.50 per share in cash; and (b) warrants to purchase 5,214,705 additional Common Shares, comprised of (i) Warrants to purchase 1,303,676 Common Shares having an exercise price of CAD 24.12 per Common Share, which Warrants will vest in the event the volume-weighted average trading price of the Common Shares on the TSX Venture Exchange or other stock exchange on which the Common Shares are listed for trading equals or exceeds CAD 48.00 for any 30 consecutive trading day period prior to the five-year anniversary of the Closing Date; and (ii) Warrants to purchase 3,911,029 Common Shares having an exercise price of CAD 28.50 per Common Share. The Warrants are exercisable for a period of five years following the Closing Date and the number of Common Shares issuable pursuant to the Warrants and the exercise prices thereof are subject to certain adjustments.
Prior to entering into the Investment Agreement, CC Capital and its affiliates did not beneficially own or control, directly or indirectly, any of the issued and outstanding Common Shares. As of the Closing Date, the Investor owns approximately 36% of the issued and outstanding Common Shares. If the Warrants were exercised in full and no other outstanding securities of Westaim were converted into Common Shares, as of the Closing Date the Investor would own approximately 44% of the issued and outstanding Common Shares. Announcement • Apr 03
The Westaim Corporation Announces Management Changes CC Capital announced pursuant to an investor rights agreement among The Westaim Corporation (Westaim), Wembley Group Partners, LP (the Investor), an affiliate of CC Capital, and Arena Investors Group Holdings, LLC (AIGH) dated as of April 3, 2025 (the Investor Rights Agreement), Mr. Chinh Chu, Founder and Senior Managing Director of CC Capital has been appointed Executive Chair of the Westaim Board and Ian Delaney has transitioned to Vice Chair of the Westaim Board. In addition, pursuant to the Investor Rights Agreement, the size of the Westaim Board has been increased to 11 with four additional CC Capital nominees having been appointed as directors of Westaim, being Ms. Deanna Mulligan, former CEO and Chair of Guardian Life Insurance, Douglas Newton, Matthew Skurbe and Richard DiBlasi, as well as one director mutually selected by Westaim and CC Capital having been appointed, being Menes Chee. Dan Zwirn, CEO and Chief Investment Officer of Arena Investors, LP, will also be an observer on the Westaim Board. John Gildner and Lisa Mazzocco resigned from the Westaim Board. Further, Mr. Matthew Skurbe has been appointed as Chief Risk Officer of Westaim. Reported Earnings • Mar 27
Full year 2024 earnings released: US$0.75 loss per share (vs US$7.98 profit in FY 2023) Full year 2024 results: US$0.75 loss per share (down from US$7.98 profit in FY 2023). Revenue: US$38.6m (down 82% from FY 2023). Net loss: US$16.2m (down 109% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 31% per year. Buy Or Sell Opportunity • Feb 20
Now 21% undervalued Over the last 90 days, the stock has risen 5.8% to CA$31.41. The fair value is estimated to be CA$39.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 59% over the last 3 years. Earnings per share has grown by 56%. Announcement • Jan 08
The Westaim Corporation Appoints Menes Chee as Independent Non-Executive Director The Westaim Corporation announced that it will appoint Menes O. Chee to its Board of Directors as an independent, non-executive director upon the closing of the Company’s previously announced transaction with CC Capital, a private investment firm focused on investing in and operating high-quality businesses for the long term. Mr. Chee will assume the role of the Independent Director under the investor rights agreement to be entered into upon closing of the Transaction, alongside five directors to be appointed by an affiliate of CC Capital and five directors to be appointed by the Company. Mr. Chee was a Senior Managing Director of Blackstone Inc. from 2009 to 2024 and a founding partner and member of the investment committee of Blackstone’s Tactical Opportunities Group. Prior to joining Blackstone, Mr. Chee served as a Principal at TPG-Axon Capital and a private equity investment professional at Texas Pacific Group. He began his career at Donaldson Lufkin & Jenrette in the Leveraged Finance Group and worked at Credit Suisse First Boston in the Merchant Banking Group. Mr. Chee has served on numerous boards, including Ellington Residential Mortgage REIT, Acrisure Holdings Inc., DRB Capital LLC, Lia Holdings Ltd., New Point Ltd., Philadelphia Financial Group Inc. and Viva Capital. He graduated magna cum laude from the University of Pennsylvania with a B.S. in Economics from the Wharton School and a B.A. from the College of Arts and Sciences, where he was elected to Phi Beta Kappa. Announcement • Jan 03
The Westaim Corporation Announces Management Changes The Westaim Corporation has made certain changes to its management team. Robert Kittel has stepped down from his positions as Chief Operating Officer and Corporate Secretary of Westaim, and Ian Delaney has moved from Executive Chair of the Company’s board of directors to Chair of the Company’s board of directors, effective December 31, 2024. While stepping down from these officer roles, Mr. Kittel will serve as Chief Operating Officer of Westaim’s newly formed wholly-owned Canadian subsidiary, Westaim Canada Services Corporation. J. Cameron MacDonald will succeed Mr. Kittel as Corporate Secretary of the Company, while continuing in his roles as President and Chief Executive Officer of the Company. Reported Earnings • Nov 14
Third quarter 2024 earnings released: US$0.009 loss per share (vs US$0.17 profit in 3Q 2023) Third quarter 2024 results: US$0.009 loss per share (down from US$0.17 profit in 3Q 2023). Revenue: US$11.4m (down 54% from 3Q 2023). Net loss: US$1.17m (down 105% from profit in 3Q 2023). Revenue is expected to decline by 126% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Canada are expected to grow by 39%. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Announcement • Oct 11
The Westaim Corporation announced that it expects to receive CAD 343.827501 million in funding from CC Capital The Westaim Corporation announced a private placement that it will issue 72,384,737 common shares at an issue price of CAD 4.75 per share and warrants that will represent an approximately 41% interest in the company for the aggregate gross proceeds of CAD 343,827,501 on October 9, 2024. The transaction will include participation from CC Capital. The parties expect to complete the transaction by the end of the first quarter of 2025, subject to receipt of certain regulatory approvals including, without limitation, approval of the TSXV, approval by Westaim shareholders and satisfaction of other customary closing conditions. Valuation Update With 7 Day Price Move • Oct 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CA$4.72, the stock trades at a trailing P/E ratio of 6.9x. Average forward P/E is 11x in the Capital Markets industry in Canada. Total returns to shareholders of 78% over the past three years. Announcement • Sep 11
An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million. An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million on September 10, 2024. The Westaim Corporation sold the remaining 1,919,639 common shares it held.
An undisclosed buyer completed the acquisition of an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) on September 10, 2024. Buy Or Sell Opportunity • Aug 16
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.5% to CA$3.95. The fair value is estimated to be CA$4.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 74% over the last 3 years. Earnings per share has grown by 77%. Reported Earnings • Aug 15
Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 profit in 2Q 2023) Second quarter 2024 results: US$0.13 loss per share (down from US$0.22 profit in 2Q 2023). Net loss: US$17.1m (down 154% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • May 16
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 10% to CA$3.97. The fair value is estimated to be CA$3.30, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 89% over the last 3 years. Meanwhile, the company has become profitable. Price Target Changed • Apr 02
Price target decreased by 8.7% to CA$4.75 Down from CA$5.20, the current price target is provided by 1 analyst. New target price is 32% above last closing price of CA$3.60. Stock is up 24% over the past year. The company posted earnings per share of US$1.33 last year. Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: US$1.36 (vs US$0.13 in FY 2022) Full year 2023 results: EPS: US$1.36 (up from US$0.13 in FY 2022). Revenue: US$212.8m (up US$185.3m from FY 2022). Net income: US$184.0m (up US$166.0m from FY 2022). Profit margin: 87% (up from 66% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Mar 08
The Westaim Corporation, Annual General Meeting, May 16, 2024 The Westaim Corporation, Annual General Meeting, May 16, 2024. Reported Earnings • Nov 17
Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.12 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.17 (up from US$0.12 loss in 3Q 2022). Net income: US$23.1m (up US$39.8m from 3Q 2022). Revenue is expected to decline by 115% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Canada are expected to grow by 2.4%. Over the last 3 years on average, earnings per share has increased by 124% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Announcement • Sep 22
the Westaim Corporation Announces Appointment of Michael Siegel Independent Director The Westaim Corporation announce the appointment of Michael Siegel to its board of directors as an independent non-executive director, effective September 21, 2023. Michael Siegel is the Founder and CEO of Legeis Capital, an advisory firm focused on the intersection of insurance and asset management. Prior to forming Legeis Capital, Michael was a Managing Director at RBC Capital Markets and served as the President & CEO of RBC Alternative Asset Management, LLC. He previously held investment management roles at hedge fund advisors CR Intrinsic Investors and DKR Capital. Michael began his career as a corporate and securities attorney at Covington & Burling LLP. He received a law degree from Harvard Law School and received his undergraduate degree in policy analysis and economics from Cornell University. Recent Insider Transactions • Sep 19
President recently sold CA$341k worth of stock On the 12th of September, John MacDonald sold around 96k shares on-market at roughly CA$3.56 per share. This transaction amounted to 2.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was John's only on-market trade for the last 12 months. Recent Insider Transactions • Sep 10
Key Executive recently sold CA$167k worth of stock On the 5th of September, Ian Delaney sold around 47k shares on-market at roughly CA$3.56 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Ian has been a net buyer over the last 12 months, purchasing a net total of CA$638k worth of shares. Announcement • Aug 22
Arena Investors, LP Issues a Letter to Board of Directors of Charge Enterprises On August 21, 2023, Arena Investors, LP announced that it has sent a letter to the board of directors of Charge Enterprises to take immediate action to address significant underperformance and believes enhanced strategic direction, leadership and governance will position the Company for substantial value creation to benefit all stakeholders. However, the current board of directors and management have failed to take immediate actions to address these issues despite Arena's multiple attempts to engage on these matters and appear to be a roadblock to the much-needed changes that are required for the Company to reverse its disturbing trend of poor operational execution and stock performance. Reported Earnings • Aug 17
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: US$35.9m (up US$35.5m from 2Q 2022). Net income: US$31.4m (up US$32.9m from 2Q 2022). Profit margin: 87% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 125% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Board Change • Jun 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Kevin Parker was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • May 26
Chief Financial Officer recently bought CA$79k worth of stock On the 19th of May, Glenn MacNeil bought around 25k shares on-market at roughly CA$3.16 per share. This transaction amounted to 7.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Glenn has been a buyer over the last 12 months, purchasing a net total of CA$136k worth in shares. Reported Earnings • May 18
First quarter 2023 earnings released: EPS: US$0.67 (vs US$0.025 in 1Q 2022) First quarter 2023 results: EPS: US$0.67 (up from US$0.025 in 1Q 2022). Revenue: US$98.8m (up US$91.8m from 1Q 2022). Net income: US$94.5m (up US$91.0m from 1Q 2022). Profit margin: 96% (up from 50% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 31
Full year 2022 earnings released: EPS: US$0.13 (vs US$0.20 in FY 2021) Full year 2022 results: EPS: US$0.13 (down from US$0.20 in FY 2021). Revenue: US$27.4m (down 19% from FY 2021). Net income: US$18.0m (down 36% from FY 2021). Profit margin: 66% (down from 84% in FY 2021). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Jan 27
Insider recently bought CA$359k worth of stock On the 24th of January, Parag Shah bought around 125k shares on-market at roughly CA$2.87 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$1.2m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Jan 26
Chief Financial Officer recently bought CA$57k worth of stock On the 23rd of January, Glenn MacNeil bought around 20k shares on-market at roughly CA$2.83 per share. This transaction amounted to 6.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Glenn's only on-market trade for the last 12 months. Price Target Changed • Nov 17
Price target increased to CA$4.50 Up from CA$4.00, the current price target is provided by 1 analyst. New target price is 81% above last closing price of CA$2.48. Stock is down 4.2% over the past year. The company posted earnings per share of US$0.20 last year. Reported Earnings • Nov 13
Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.011 profit in 3Q 2021) Third quarter 2022 results: US$0.12 loss per share (down from US$0.011 profit in 3Q 2021). Net loss: US$16.8m (down US$18.4m from profit in 3Q 2021). Revenue is forecast to grow 152% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Canada are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 12
Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.076 profit in 2Q 2021) Second quarter 2022 results: US$0.011 loss per share (down from US$0.076 profit in 2Q 2021). Revenue: US$388.0k (down 96% from 2Q 2021). Net loss: US$1.58m (down 115% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 222% compared to a 1.3% decline forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Recent Insider Transactions • Jun 17
Insider recently bought CA$496k worth of stock On the 14th of June, Parag Shah bought around 200k shares on-market at roughly CA$2.48 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$8.4m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Jun 01
Lead Independent Director recently bought CA$260k worth of stock On the 30th of May, Stephen Cole bought around 100k shares on-market at roughly CA$2.60 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$7.9m more in shares than they have sold in the last 12 months. Price Target Changed • May 18
Price target increased to CA$4.50 Up from CA$3.90, the current price target is provided by 1 analyst. New target price is 73% above last closing price of CA$2.60. Stock is down 0.8% over the past year. The company posted earnings per share of US$0.20 last year. Announcement • May 04
The Westaim Corporation to Report Q1, 2022 Results on May 17, 2022 The Westaim Corporation announced that they will report Q1, 2022 results Pre-Market on May 17, 2022 Reported Earnings • Apr 14
Full year 2021 earnings released Full year 2021 results: Revenue: US$33.7m (down 230% from FY 2020). Net income: US$28.2m (up US$62.6m from FY 2020). Profit margin: 84% (down from 132% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Announcement • Apr 09
The Westaim Corporation to Report Q4, 2021 Results on Apr 15, 2022 The Westaim Corporation announced that they will report Q4, 2021 results on Apr 15, 2022 Recent Insider Transactions • Jan 28
Insider recently bought CA$121k worth of stock On the 24th of January, Parag Shah bought around 50k shares on-market at roughly CA$2.42 per share. In the last 3 months, there was an even bigger purchase from another insider worth CA$1.7m. Insiders have collectively bought CA$9.2m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Dec 08
Insider recently bought CA$636k worth of stock On the 3rd of December, James Hays bought around 250k shares on-market at roughly CA$2.54 per share. In the last 3 months, they made an even bigger purchase worth CA$1.7m. Insiders have collectively bought CA$8.9m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Nov 26
Insider recently bought CA$154k worth of stock On the 22nd of November, James Hays bought around 60k shares on-market at roughly CA$2.59 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$6.8m more in shares than they have sold in the last 12 months. Reported Earnings • Nov 20
Third quarter 2021 earnings released The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: US$3.80m (down 6.1% from 3Q 2020). Net income: US$1.59m (up 143% from 3Q 2020). Profit margin: 42% (up from 16% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Sep 12
Chief Financial Officer recently bought CA$86k worth of stock On the 9th of September, Glenn MacNeil bought around 32k shares on-market at roughly CA$2.70 per share. In the last 3 months, there was an even bigger purchase from another insider worth CA$2.9m. Glenn has been a buyer over the last 12 months, purchasing a net total of CA$171k worth in shares. Recent Insider Transactions • Aug 29
Insider recently bought CA$2.9m worth of stock On the 26th of August, James Hays bought around 1m shares on-market at roughly CA$2.43 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$12m more in shares than they have sold in the last 12 months. Reported Earnings • Aug 20
Second quarter 2021 earnings released Second quarter 2021 results: Revenue: US$10.5m (up 182% from 2Q 2020). Net income: US$10.9m (up US$11.0m from 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Jul 28
Insider recently bought CA$1.5m worth of stock On the 19th of July, James Hays bought around 750k shares on-market at roughly CA$2.00 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$9.3m more in shares than they have sold in the last 12 months. Reported Earnings • May 23
First quarter 2021 earnings released The company reported a soft first quarter result with weaker revenues and profit margins, although earnings were improved. First quarter 2021 results: Revenue: US$12.7m (down 153% from 1Q 2020). Net income: US$9.09m (up US$29.5m from 1Q 2020). Profit margin: 72% (down from 86% in 1Q 2020). The decrease in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Apr 20
Insider recently sold CA$70k worth of stock On the 16th of April, Donald Larson sold around 25k shares on-market at roughly CA$2.81 per share. In the last 3 months, they made an even bigger sale worth CA$305k. Despite this recent sale, insiders have collectively bought CA$17m more than they sold in the last 12 months. Recent Insider Transactions • Apr 18
Insider recently sold CA$70k worth of stock On the 16th of April, Donald Larson sold around 25k shares on-market at roughly CA$2.81 per share. In the last 3 months, they made an even bigger sale worth CA$305k. Despite this recent sale, insiders have collectively bought CA$17m more than they sold in the last 12 months. Recent Insider Transactions • Mar 31
Executive Chairman of the Board recently bought CA$437k worth of stock On the 29th of March, Ian Delaney bought around 165k shares on-market at roughly CA$2.65 per share. This was the largest purchase by an insider in the last 3 months. This was Ian's only on-market trade for the last 12 months. Reported Earnings • Mar 27
Full year 2020 earnings released Full year 2020 results: Net loss: US$34.4m (down US$42.9m from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Announcement • Mar 19
The Westaim Corporation, Annual General Meeting, May 26, 2021 The Westaim Corporation, Annual General Meeting, May 26, 2021. Is New 90 Day High Low • Feb 02
New 90-day high: CA$2.63 The company is up 12% from its price of CA$2.34 on 03 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period. Announcement • Jan 28
The Westaim Corporation to Report Q4, 2020 Results on Mar 25, 2021 The Westaim Corporation announced that they will report Q4, 2020 results After-Market on Mar 25, 2021 Is New 90 Day High Low • Jan 16
New 90-day high: CA$2.56 The company is up 8.0% from its price of CA$2.37 on 16 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 11% over the same period. Price Target Changed • Jan 07
Price target raised to CA$3.90 Up from CA$3.53, the current price target is provided by 1 analyst. The new target price is 62% above the current share price of CA$2.41. As of last close, the stock is down 5.9% over the past year. Is New 90 Day High Low • Dec 31
New 90-day high: CA$2.49 The company is up 7.0% from its price of CA$2.32 on 02 October 2020. The Canadian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 17% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: CA$2.44 The company is up 9.0% from its price of CA$2.23 on 16 September 2020. The Canadian market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Capital Markets industry, which is up 14% over the same period. Recent Insider Transactions • Dec 04
Insider recently bought CA$581k worth of stock On the 30th of November, James Hays bought around 250k shares on-market at roughly CA$2.32 per share. In the last 3 months, they made an even bigger purchase worth CA$2.2m. Insiders have collectively bought CA$16m more in shares than they have sold in the last 12 months. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS US$0.005 Third quarter 2020 results: Net income: US$655.0k (down 83% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 19
New 90-day high: CA$2.42 The company is up 22% from its price of CA$1.99 on 21 July 2020. The Canadian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 3.0% over the same period. Recent Insider Transactions • Oct 01
Insider recently bought CA$316k worth of stock On the 25th of September, James Hays bought around 143k shares on-market at roughly CA$2.21 per share. In the last 3 months, there was an even bigger purchase from another insider worth CA$945k. Insiders have collectively bought CA$12m more in shares than they have sold in the last 12 months. Is New 90 Day High Low • Oct 01
New 90-day high: CA$2.28 The company is up 13% from its price of CA$2.01 on 03 July 2020. The Canadian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period. 
